Rephonic
Artwork for Gastrointestinal Cancer Update

Gastrointestinal Cancer Update

Dr. Neil Love
Colorectal Cancer
Immunotherapy
Biliary Tract Cancers
Circulating Tumor DNA
Gastroesophageal Cancer
Gastroesophageal Cancers
Clinical Trials
Hepatocellular Carcinoma
Hepatobiliary Cancers
Immune Checkpoint Inhibitors
Targeted Therapy
HER2
Adjuvant Chemotherapy
Cholangiocarcinoma
Biliary Tract Cancer
Desmoid Tumors
Adjuvant Therapy
Neuroendocrine Tumors
Neuroendocrine Carcinoma
Chemotherapy

This series bridges the gap between research and patient care by providing medical oncologists and hematologists with ongoing access to the perspectives and opinions of national and international clinical investigators with expertise in gastrointestinal cancers.

PublishesWeeklyEpisodes322Founded20 years ago
Number of ListenersCategories
Health & FitnessScienceMedicine

Listen to this Podcast

Artwork for Gastrointestinal Cancer Update

Latest Episodes

Featuring perspectives from Dr Eileen M O’Reilly and Dr Philip A Philip, including the following topics:

• Introduction (0:00)

• Optimal Incorporation of Chemotherapy into the Management of Advanced Pancreatic Cancer — Dr Philip (7:27)

• Other Avai... more

Prof Bernd Kasper from the Mannheim Cancer Center in Mannheim, Germany, discusses recent updates on available and novel treatment strategies for desmoid tumors.

CME information and select publications here.

Dr Jaffer A Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Rutika Mehta from Weill Cornell Medicine in New York, New York, Dr John Strickler from Duke University in Durham, North Carolina, and moderator Dr Samuel J Klempn... more

Dr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical finding... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Lung Cancer Update
Lung Cancer UpdateDr. Neil Love
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
Two Onc Docs
Two Onc DocsSam and Karine

Recent Guests

Bernd Kasper
Professor, University of Heidelberg, Mannheim Cancer Center
University of Heidelberg
Episode: Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper
Jaffer Ajani
Oncologist at MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Rutika Mehta
Oncologist at Weill Cornell Medical Center
Weill Cornell Medical Center
Episode: Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
John Strickler
Oncologist at Duke University
Duke University
Episode: Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Haley Ellis
Facility: Massachusetts General Hospital and Harvard Medical School
Massachusetts General Hospital / Harvard Medical School
Episode: HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Eric Van Cutsem
Faculty from University Hospitals Leuven
University Hospitals Leuven, Leuven, Belgium
Episode: HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Zev Wainberg
Faculty from UCLA School of Medicine
UCLA School of Medicine
Episode: HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Ravin Ratan
From the MD Anderson Cancer Center, Houston
MD Anderson Cancer Center
Episode: Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Christopher Lieu
Medical oncologist at University of Colorado Cancer Center
University of Colorado Cancer Center
Episode: Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis

Hosts

Neil Love
Medical Oncologist and CME program host; frequently featured as a primary host or moderator.
Christopher Lieu
Medical oncologist; moderator on GI cancer updates and CTDNA/MRD discussions.

Reviews

4.3 out of 5 stars from 23 ratings
  • Gastrointestinal Cancers

    Podcast Addict
    5
    Donald Gravenor
    6 years ago

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#28
United Arab Emirates/Science
Apple Podcasts
#203
South Africa/Science

Talking Points

Recent interactions between the hosts and their guests.

HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Q: Would you consider TDXD in the second line for a patient with 2+ HER2 status or who has a 2+ISH- or similar discordance?
If the tumor shows strong HER2 amplification and the disease biology supports HER2 targeting, TDXD is favored in appropriate contexts; there is caution about lower copy number or ambiguous HER2 IHC status.
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Q: Assuming that an Atomab gets approved, in what patients are you using it with or without Ticillizumab?
The panelists anticipate using the regimen with Ticillizumab in patients most likely to benefit, highlighting a potential median overall survival advantage over control, based on current data discussions.
Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis
Q: How can CTDNA testing influence decision-making in stage II and stage III colorectal cancer?
In stage II, CTDNA can help decide whether to escalate therapy in positive cases or de-escalate when negative, and in stage III it can similarly tailor chemotherapy duration and intensity, with data showing that testing can reduce unnecessary chemotherapy while maintaining outcomes.
Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis
Q: What are the main strategies for detecting circulating tumor DNA, and how do they differ?
There are tumor-naive (tumor-uninformed) assays that broadly look for abnormal DNA changes and are faster, and tumor-informed assays that sequence a patient's tumor to identify specific alterations and then look for those exact changes in blood, offering higher sensitivity but requiring more time.
Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis
Q: What is molecular residual disease analysis and why is it clinically relevant in colorectal cancer?
CTDNA/molecular residual disease analysis detects tumor DNA fragments in blood, offering prognostic information and guiding adjuvant therapy decisions beyond what imaging and pathology provide.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Gastrointestinal Cancer Update

What is Gastrointestinal Cancer Update about and what kind of topics does it cover?

A high-signal, clinician-focused show that translates GI cancer research into practical guidance for patient management. Episodes frequently center on biomarker-driven decisions (MRD/CTDNA, MSI status, HER2, PD-L1), sequencing of therapies, and real-world case-based discussions from major conferences. The format leans into CME-style, expert-led panels and physician-to-physician dialogues, often featuring multidisciplinary perspectives from leading cancer centers. A standout trait is the integration of conference data (ASCO GI) with pragmatic treatment decisions, including toxicity management and care pathways, making it valuable for oncologists seeking to stay current with actionable insights and trial updates.

Where can I find podcast stats for Gastrointestinal Cancer Update?

Rephonic provides a wide range of podcast stats for Gastrointestinal Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Gastrointestinal Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Gastrointestinal Cancer Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Gastrointestinal Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Gastrointestinal Cancer Update?

Rephonic provides comprehensive predictive audience data for Gastrointestinal Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Gastrointestinal Cancer Update have?

To see how many followers or subscribers Gastrointestinal Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Gastrointestinal Cancer Update?

These podcasts share a similar audience with Gastrointestinal Cancer Update:

1. Lung Cancer Update
2. ASCO Daily News
3. Two Onc Docs
4. Prostate Cancer Update
5. Breast Cancer Update

How many episodes of Gastrointestinal Cancer Update are there?

Gastrointestinal Cancer Update launched 20 years ago and published 322 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Gastrointestinal Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Gastrointestinal Cancer Update?

Rephonic pulls ratings and reviews for Gastrointestinal Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Gastrointestinal Cancer Update?

Rephonic provides full transcripts for episodes of Gastrointestinal Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Gastrointestinal Cancer Update?

Recent guests on Gastrointestinal Cancer Update include:

1. Bernd Kasper
2. Jaffer Ajani
3. Rutika Mehta
4. John Strickler
5. Haley Ellis
6. Eric Van Cutsem
7. Zev Wainberg
8. Ravin Ratan

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days